Accéder au contenu
Merck
  • Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies.

Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies.

Cell reports (2020-02-13)
Zachary A Silver, Aristotelis Antonopoulos, Stuart M Haslam, Anne Dell, Gordon M Dickinson, Michael S Seaman, Ronald C Desrosiers
RÉSUMÉ

Approximately 50% of the mass of the Envelope (Env) glycoprotein surface subunit (gp120) of human immunodeficiency virus type 1 (HIV-1) is composed of N-linked carbohydrate. Until now, the dogma has been that HIV-1 lacks O-linked carbohydrate on Env. Here we show that a subset of patient-derived HIV-1 isolates contain O-linked carbohydrate on the variable 1 (V1) domain of Env gp120. We demonstrate the presence of this O-glycosylation both on virions and on gp120 expressed as a secreted protein. Further, we establish that these O-linked glycans can confer a more than 1,000-fold decrease in neutralization sensitivity (IC50) to V3-glycan broadly neutralizing antibodies. These findings uncover a structural modification to the HIV-1 Env and suggest a functional role in promoting viral escape from one category of broadly neutralizing antibodies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3,4-Diaminobenzophenone, 97%
Supelco
Dowex 50WX8, hydrogen form, strongly acidic, 50-100 mesh